FDA and outliers [Study As­sess­ment]

posted by mittyri – Russia, 2018-12-11 15:38  – Posting: # 19681
Views: 3,160

Dear Mann,

I don't think the position of FDA is different.
Please see this old post.

Do you have any experience of BEQ analysis for submission in FDA/EMA jurisdiction?
Where is the idea of outliers coming from?
Do the results without any outliers analysis also show not-BE?

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
20,242 posts in 4,259 threads, 1,397 registered users;
online 16 (0 registered, 16 guests [including 11 identified bots]).
Forum time (Europe/Vienna): 05:59 UTC

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5